Search by keywords: Upcoming Seminars and Events View upcoming seminars and events. Learn more 574 News Items found Roundup Highlights from MSK at the 2018 American Association for Cancer Research Meeting Monday, April 16, 2018 Read up on the latest developments in several key areas of cancer research, including genomic mapping, disease modeling through CRISPR, CAR T therapy, and cancer stem cells. Outreach Growing Cells and Future Scientists: MSK Hosts High School Students for Day of Exploration Friday, March 30, 2018 Students from Manhattan’s Urban Academy Laboratory School paid a visit to Marcel van den Brink’s lab at MSK. In Brief Can You Hear Me Now? Scientists Find Nanoparticles Have a Language of Their Own Monday, March 26, 2018 Nanoparticles were thought of a silent partner in imaging technologies. They’re now being recognized as an important source of subatomic chatter. In the Clinic Experimental Cancer Drug Developed at MSK Leads to New Approach for Treating Alzheimer's Disease Thursday, March 1, 2018 A family of drugs developed at MSK targets disrupted processes in cells in diseases related to aging. In Brief Scientists Identify How Gene Mutation Drives a Deadly Childhood Cancer Thursday, March 1, 2018 Synovial sarcoma is an aggressive cancer primarily affecting children and young adults. A new study gets to the bottom of it. In the Clinic Single-Cell Analysis Enables Researchers to Understand the Differences within Tumors Tuesday, February 27, 2018 Scientists are decoding the genetic changes that drive individual cancer cells. This may help them develop more-effective targeted therapies. In the Clinic Chemotherapy-Immunotherapy Combination Aims to Knock Out Melanoma with a One-Two Punch Friday, February 2, 2018 A new approach for treating melanoma combines the immunotherapy drug ipilimumab with chemotherapy that treats only the area affected by cancer. In the Clinic Longest-Running CAR T Trial Shows Which Patients Benefit Most, Have Fewest Side Effects Wednesday, January 31, 2018 The study represents 20 years of research at MSK. New Study Examines the Longest-Running CAR T Cell Trial and Finds Acute Lymphoblastic Leukemia Patients May Do Better When Treated Early Wednesday, January 31, 2018 Researchers at Memorial Sloan Kettering (MSK) report today in the New England Journal of Medicine that adult patients with acute lymphoblastic leukemia (ALL) who received chimeric antigen receptor (CAR) T cell therapy responded better if they had a small amount of disease at the time of the treatment. Compared with patients with a greater amount of disease, those in the low-disease category lived significantly longer and experienced fewer life-threatening side effects. In the Lab Scientists Create First-of-Its-Kind Metabolic Road Map of Cancer Wednesday, January 24, 2018 The online resource will serve as a benchmark for researchers studying metabolism and cancer. Pagination First page « First Previous page ‹ Previous … Page 31 Page 32 Page 33 Page 34 Current page 35 Page 36 Page 37 Page 38 Page 39 … Next page Next › Last page Last »